Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 3

Indexed by

Indexed by DOAJ

Article Access statistics

Viewed: 184

Emailed: 0

PDF Downloaded: 210

Panacea Journal of Medical Sciences


Old wine in new bottle


Full Text PDF Share on Facebook Share on Twitter


Case Report

Author Details : Niladri Chakraborty, Santa Subhra Chatterjee*

Volume : 14, Issue : 2, Year : 2024

Article Page : 602-606

https://10.18231/j.pjms.2024.107

Article Metrics



Suggest article by email


Abstract

For the last one and half years, COVID-19 pandemic has become a medical challenge all over the world. Patients fulfill criteria for Kawasaki disease in a substantial proportion of cases. MIS-C tends to occurr in previously healthy patients. MIS-C tends to affect black and Hispanic individuals. On the other hand Kawasaki disease tends to affect more of Asian population. The author reports a case of post COVID MIS-C in a 13 years child who presented with fever for 4 days and hypotension. Physical examination revealed left sided lymphadenopathy in neck, tachycardia and tachypnea. Investigations showed elevated CRP, ESR, D-dimer, PT-INR, ferritin, procalcitonin, very high antibody titer of SARS COV-2 IgG and low platelet count. Patient was treated with IV methylprednisolone, IV immunoglobulin, IV meropenem, SC enoxaparin and Tab aspirin. His condition gradually improved, BP normalised, and heart rate decreased and fever subsided. This case report emphasises that early recognition and concomitant treatment of COVID related MIS-C can enhance good outcome and negate potentially life threatening complications.
 

Keywords: MIS (Multisystem inflammatory syndrome), SARS CoV2 IgG, lymphadenopathy, KD (Kawasaki disease)


How to cite : Chakraborty N, Chatterjee S S, Old wine in new bottle. Panacea J Med Sci 2024;14(2):602-606

Copyright © 2024 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)